FDAFDA · Food and drugs·Recall number D-0611-2026
Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.
Published July 1, 2026 · Recall initiated: May 28, 2026
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations
What to do
Voluntary: Firm initiated
Recall details
- Brand
- FENOFIBRATE
- Manufacturer
- Ajanta Pharma USA Inc
- Distributor
- U.S. Nationwide
- UPC
- 0327241119040
- Lot
- Lot # PA02216; Exp. 12/2029
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.